Article
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression between patients
2024-12-12
Abstract excerpt
Genetic alterations alone cannot account for the diverse phenotypes of cancer cells. Even cancers with the same driver mutation show significant transcriptional heterogeneity and varied responses to therapy. However, the mechanisms underpinning this heterogeneity remain under-explored. Here, we find that novel enhancer usage is a common feature in acute lymphoblastic leukemia (ALL). In particular, KMT2A::AFF1 ALL...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3fc6e5fe-4d85-558c-83f6-d728d49aaa4f
- DOI
- 10.1101/2024.12.08.627394
